287 related articles for article (PubMed ID: 28670371)
1. Circulating tumor cells: what we know, what do we want to know about them and are they ready to be used in clinics?
Bielčiková Z; Jakabová A; Pinkas M; Zemanová M; Kološtová K; Bobek V
Am J Transl Res; 2017; 9(6):2807-2823. PubMed ID: 28670371
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success.
Ušiaková Z; Mikulová V; Pintérová D; Brychta M; Valchář J; Kubecová M; Tesařová P; Bobek V; Kološtová K
In Vivo; 2014; 28(4):605-14. PubMed ID: 24982230
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer.
Shishido SN; Carlsson A; Nieva J; Bethel K; Hicks JB; Bazhenova L; Kuhn P
J Transl Med; 2019 Aug; 17(1):294. PubMed ID: 31462312
[TBL] [Abstract][Full Text] [Related]
4. Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.
Wendel M; Bazhenova L; Boshuizen R; Kolatkar A; Honnatti M; Cho EH; Marrinucci D; Sandhu A; Perricone A; Thistlethwaite P; Bethel K; Nieva J; Heuvel Mv; Kuhn P
Phys Biol; 2012 Feb; 9(1):016005. PubMed ID: 22307026
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells in breast cancer: functional heterogeneity, pathogenetic and clinical aspects.
Cherdyntseva NV; Litviakov NV; Denisov EV; Gervas PA; Cherdyntsev ES
Exp Oncol; 2017 Mar; 39(1):2-11. PubMed ID: 28361862
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of Circulating Tumor Cells by a Combination of Immunomagnetic Enrichment and RT-PCR in Colorectal Cancer Patients Undergoing Surgery.
Vojtechova G; Benesova L; Belsanova B; Minarikova P; Levy M; Lipska L; Suchanek S; Zavoral M; Minarik M
Adv Clin Exp Med; 2016; 25(6):1273-1279. PubMed ID: 28028983
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cells: clinical validity and utility.
Cabel L; Proudhon C; Gortais H; Loirat D; Coussy F; Pierga JY; Bidard FC
Int J Clin Oncol; 2017 Jun; 22(3):421-430. PubMed ID: 28238187
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Circulating Tumor Cells in Colorectal Cancer as an Adjunctive Non-invasive Diagnostic Method.
Nursyirwan SA; Abdullah M; Sulaiman AS; Rinaldi I; Makmun D; Simadibrata M; Noor DR; Wiraatmadja A; Jeo WS; Rahadiani N; Handjari DR; Shatri H
Acta Med Indones; 2023 Oct; 55(4):385-395. PubMed ID: 38213054
[TBL] [Abstract][Full Text] [Related]
9. Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer.
Sharp A; Welti JC; Lambros MBK; Dolling D; Rodrigues DN; Pope L; Aversa C; Figueiredo I; Fraser J; Ahmad Z; Lu C; Rescigno P; Kolinsky M; Bertan C; Seed G; Riisnaes R; Miranda S; Crespo M; Pereira R; Ferreira A; Fowler G; Ebbs B; Flohr P; Neeb A; Bianchini D; Petremolo A; Sumanasuriya S; Paschalis A; Mateo J; Tunariu N; Yuan W; Carreira S; Plymate SR; Luo J; de Bono JS
Eur Urol; 2019 Nov; 76(5):676-685. PubMed ID: 31036442
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy: ready to guide therapy in advanced prostate cancer?
Hegemann M; Stenzl A; Bedke J; Chi KN; Black PC; Todenhöfer T
BJU Int; 2016 Dec; 118(6):855-863. PubMed ID: 27430478
[TBL] [Abstract][Full Text] [Related]
11. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the diagnostic value of circulating tumor cells with CytoSorter
Jin L; Zhao W; Zhang J; Chen W; Xie T; Wang L; Fan W; Xie S; Shen J; Zheng H; Hu W; Wei Q; Dong M; Wang Q; Shen J; Liu Y
Cancer Med; 2020 Mar; 9(5):1638-1647. PubMed ID: 31908156
[TBL] [Abstract][Full Text] [Related]
13. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
[No Abstract] [Full Text] [Related]
14. Longitudinal Analysis of Circulating Tumor Cells in Colorectal Cancer Patients by a Cytological and Molecular Approach: Feasibility and Clinical Application.
Hendricks A; Dall K; Brandt B; Geisen R; Röder C; Schafmayer C; Becker T; Hinz S; Sebens S
Front Oncol; 2021; 11():646885. PubMed ID: 34262858
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology.
Azevedo R; Soares J; Peixoto A; Cotton S; Lima L; Santos LL; Ferreira JA
Urol Oncol; 2018 May; 36(5):221-236. PubMed ID: 29530466
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization and heterogeneity of circulating tumor cells in breast cancer.
Jakabova A; Bielcikova Z; Pospisilova E; Matkowski R; Szynglarewicz B; Staszek-Szewczyk U; Zemanova M; Petruzelka L; Eliasova P; Kolostova K; Bobek V
Breast Cancer Res Treat; 2017 Dec; 166(3):695-700. PubMed ID: 28815327
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients.
Hauch S; Zimmermann S; Lankiewicz S; Zieglschmid V; Böcher O; Albert WH
Anticancer Res; 2007; 27(3A):1337-41. PubMed ID: 17593628
[TBL] [Abstract][Full Text] [Related]
18. Clinico-pathological correlation of serial measurement of circulating tumor cells in 24 metastatic colorectal cancer patients receiving chemotherapy reveals interpatient heterogeneity correlated with CEA levels but independent of KRAS and BRAF mutation.
Das A; Kunkel M; Joudeh J; Dicker DT; Scicchitano A; Allen JE; Sarwani N; Yang Z; Kaifi J; Zhu J; Liao J; El-Deiry WS
Cancer Biol Ther; 2015; 16(5):709-13. PubMed ID: 25806877
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients.
Li H; Li B; Pan Y; Zhang Y; Xiang J; Zhang Y; Sun Y; Yu X; He W; Hu H
Front Oncol; 2020; 10():621435. PubMed ID: 33585249
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of circulating tumor cells in blood from patients with gastric cancer.
Arigami T; Uenosono Y; Yanagita S; Okubo K; Kijima T; Matsushita D; Amatatsu M; Kurahara H; Maemura K; Natsugoe S
Ann Gastroenterol Surg; 2017 Apr; 1(1):60-68. PubMed ID: 29863113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
